What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2025-11-13 compared with 2025-08-14 · 25 added, 51 removed, 15 unchanged (84% of the section changed)

Other Information.

During the quarter ended June 30, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement”

or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.

and Plan of Merger, dated April 7, 2014, by and among Oro Capital Corporation, Synergy Merger Sub, Inc.

and Synergy Strips Corp.

(incorporated by reference to Exhibit 2.1 to the Registration Statement on Form S-1, filed by Synergy CHC Corp.

with the SEC on June

Purchase Agreement, dated January 16, 2015, by and among Synergy Strips Corp.;

Factor Nutrition Labs, LLC;

Vita Partners, LLC, RPR

Partners, LLC, and Thor Associates, Inc.

(incorporated by reference to Exhibit 2.2 to the Registration Statement on Form S-1, filed

by Synergy CHC Corp.

with the SEC on June 28, 2024)

Purchase Agreement, dated June 26, 2015, by and between Neuragen Corp.

and Knight Therapeutics, Inc.

(incorporated by reference to

Exhibit 2.3 to the Registration Statement on Form S-1, filed by Synergy CHC Corp.

with the SEC on June 28, 2024)

of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Registration Statement on Form S-1, filed by Synergy

September 30, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule

10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

The following exhibits are

filed as part of, or incorporated by reference into, this Quarterly Report.

Description of Exhibit

Articles of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Registration Statement on Form S-1, filed by Synergy CHC Corp.

with the SEC on September 16, 2024)

of Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed by Synergy

with the SEC on June 18, 2025)

and Restated Bylaws (incorporated by reference to Exhibit 3.4 to the Registration Statement on Form S-1, filed by Synergy CHC Corp.

Certificate of Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed by Synergy CHC Corp.

with the SEC on June 18, 2025)

of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K, filed by Synergy CHC Corp.

the SEC on June 12, 2025)

Agreement, dated as of May 30, 2025, by and among Synergy CHC Corp.

as Borrower, each subsidiary of the Borrower listed as a Guarantor

therein, the lenders from time-to-time party thereto as Lenders and ACP Agency, LLC, as Collateral Agent and Administrative Agent

(incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed by Synergy CHC Corp.

Amended and Restated Bylaws (incorporated by reference to Exhibit 3.4 to the Registration Statement on Form S-1, filed by Synergy CHC Corp.

with the SEC on June 28, 2024)

to Synergy CHC Corp.

2024 Equity Incentive Plan (incorporated

by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed by Synergy CHC Corp.

Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K, filed by Synergy CHC Corp.

with the SEC on June 12, 2025)

Form of Representative Warrant, dated August 27, 2025 (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K, filed by Synergy CHC Corp.

with the SEC on August 27, 2025)

Underwriting Agreement, dated August 25, 2025 by and between Synergy CHC Corp.

and Bancroft Capital, LLC, as representative of the underwriters named therein (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K, filed by Synergy CHC Corp.

with the SEC on August 27, 2025)

Rule 13a-14(a) Certification by Principal Executive Officer

3 unchanged sentences

Inline XBRL Instance Document